SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2012
ROCKWELL MEDICAL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
30142 Wixom Road,
|(Address of principal executive offices)||(Zip Code)|
Registrants telephone number, including area code (248) 960-9009
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|¨||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|¨||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|¨||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|¨||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 24, 2012, Rockwell Medical Technologies, Inc. (the Company) held its Annual Meeting of Shareholders. At the Annual Meeting, as noted in Item 5.07 below, the shareholders approved an amendment to the Companys 2007 Long Term Incentive Plan (the LTIP), which had been previously approved by the Board of Directors of the Company on March 5, 2012 subject to shareholder approval. The amendment increases the total number of common shares subject to the LTIP from 4,500,000 to 6,250,000 shares.
Item 5.07 Submission of Matters to a Vote of Security Holders.
At the Companys Annual Meeting of Shareholders on May 24, 2012, the shareholders voted to (1) reelect two incumbent directors for a term expiring in 2015, (2) amend the Companys Restated Articles of Incorporation to change the Companys name, (3) amend the LTIP to increase the total number of common shares subject to the LTIP, and (4) ratify the selection of Plante & Moran, PLLC as the Companys independent registered public accounting firm for 2012. The following tables set forth the final voting results on each matter.
Patrick J. Bagley
Robert L. Chioini
Approve amendment to Restated Articles of Incorporation
Approve amendment to LTIP
Ratify the selection of Plante & Moran, PLLC
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|ROCKWELL MEDICAL TECHNOLOGIES, INC.|
|Date: May 30, 2012||By:|
|Thomas E. Klema|
|Its: Chief Financial Officer|